Radical trachelectomy for cervical cancer
 

A radical trachelectomy is surgery that removes the cervix and the pelvic lymph nodes. Cervical cerclage is done at the same time. The uterus is left so that later, pregnancy could occur. If pregnancy does occur, delivery would be done by cesarean (C-section).

Radical trachelectomy may be a treatment option for some young women with early stages (stage IA2 or IB1) of cervical cancer who hope to preserve their fertility. Women who have had this procedure have high rates of miscarriage and early delivery.1 Most doctors have limited experience with this procedure. It is not commonly used.

The risks of a radical trachelectomy include the progression of cervical cancer, infertility, and increased rates of miscarriage.

Citations

  1. Koliopoulos G, et al. (2004). Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility. Gynecologic Oncology, 93(2): 469–473.

Author: Bets Davis, MFALast Updated: September 5, 2008
Medical Review: Anne C. Poinier, MD - Internal Medicine
Kevin Holcomb, MD - Gynecologic Oncology
 Top of Page Top of Page 
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Latest Cervical Cancer News
Experimental vaccine cures pre-cancer vulvar growths

November 5, 2009 — BOSTON (Reuters) - An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four out of five, researchers in the Netherlands reported on Wednesday.

Many doctors overuse Pap testing: survey

November 2, 2009 — NEW YORK (Reuters Health) - Many U.S. primary care doctors are out of step with guidelines on Pap testing for cervical cancer -- largely because they overuse the test, according to a study published Monday.

US advisers decline to push Gardasil for boys

October 21, 2009 — WASHINGTON (Reuters) - U.S. vaccine advisers on Wednesday declined to press for the use of Merck & Co's Gardasil in boys and men, opting instead for "permissive" use.

Select news items provided by Reuters Health